Identifying and reducing barriers to oncology clinical research at the site level
Within the field of oncology, there are almost 800 medicines currently in clinical development (PhRMA Cancer Medicines in Development Report, 2014), translating to over 3,100 active cancer clinical trials in the US alone. Of these, 1,824 are now seeking volunteers to participate or have not yet started recruiting patients.
If clinical research is to be successful and generate new treatments that really make a difference to cancer patient’s lives and those of their friends and families, industry and clinical teams need to optimise their working relationships.
This white paper provides specific ideas and innovative approaches that can make a real difference to the successful conduct of industry-sponsored clinical trials by improving the Research Team Experience.
Download the whitepaper
Identifying and Reducing Barriers to Oncology Clinical Research at the Site Level